Aerin Medical Overview
- Founded
- 2011
- Status
- Private
- Employees
- 74
- Latest Deal Type
- Series E
- Latest Deal Amount
- $48M
- Investors
- 9
Aerin Medical General Information
Description
Developer of non-invasive treatment device designed to improve symptoms of nasal breathing disorders. The company's device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway safely and effectively.
Contact Information
Website
www.aerinmedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Primary Office
- 232 East Caribbean Drive
- Sunnyvale, CA 94089
- United States
+1 (678) 000-0000
Aerin Medical Timeline
Aerin Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series E) | 17-Aug-2020 | $48M | 00000 | 00000 | Completed | Generating Revenue |
| 7. Debt Refinancing | 22-May-2019 | 0000 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series D) | 19-Dec-2017 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 5. Mezzanine | 13-Dec-2017 | 0000 | 000.00 | Completed | Startup | |
| 4. Later Stage VC (Series C) | 21-Mar-2016 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 3. Later Stage VC (Series C) | 13-Feb-2014 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Early Stage VC (Series B) | 12-Oct-2012 | $125K | $250K | 00.000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 12-Dec-2011 | $125K | $125K | 00.000 | Completed | Startup |
Aerin Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.0 | 00.000 |
| Series B | 646,763 | $0.001000 | $0.06 | $0.77 | $0.77 | 1x | $0.49 | 0.59% |
| Series A | 1,010,560 | $0.001000 | $0.05 | $0.57 | $0.57 | 1x | $0.4 | 0.83% |
Aerin Medical Executive Team (8)
Aerin Medical Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Thrower | Aerin Medical | Board Member | 000 0000 |
| Karen Long | KCK Group | Chairman | 000 0000 |
| Kern Bhugra | Self | Board Member | 000 0000 |
| Ryan Drant | Self | Board Member | 000 0000 |
| Scott Wolf MD | Aerin Medical | Co-Founder, Chief Medical Officer, Board Member & President | 000 0000 |
Aerin Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAerin Medical Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| OrbiMed | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Questa Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Barshop Ventures | Family Office | Minority | 000 0000 | 000000 0 | |
| David Shen Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Horizon Technology Finance | Lender/Debt Provider | Minority | 000 0000 | 000000 0 |